Evonik Industries AG

Share Issue/Capital Change • Apr 24, 2013

News Details

Ad-hoc | 24 April 2013 23:25

Evonik Industries AG: RAG Foundation and CVC successfully place additional Evonik shares

Evonik Industries AG / Key word(s): Miscellaneous

24.04.2013 23:25

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

---

NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE
UNITED STATES, AUSTRALIA, CANADA OR JAPAN OR ANY OTHER JURISDICTION IN
WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL, OTHER RESTRICTIONS ARE
APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS DISCLOSURE.

Essen, April 24, 2013. RAG Foundation and funds advised by CVC Capital
Partners today successfully placed additional Evonik Industries AG shares
exclusively with domestic and international institutional investors via an
accelerated bookbuilding. Including over-allotment option (Greenshoe)
today's placement comprised 10.718 million Evonik shares at a price of
32.20 Euro per share, representing a total placement volume of 345.1
million Euro.

The placement has been conducted by Deutsche Bank Aktiengesellschaft and
MainFirst Bank Aktiengesellschaft. Following the two private placements
closed in February and March this year of c. 12.2 percent of Evonik shares,
the free float now amounts to approximately 14.5 percent.

On April 24, 2013 the entire Evonik share capital of 466 million shares has
been admitted to trading in the regulated market (Prime Standard) of the
Frankfurt Stock Exchange as well as in the regulated market of the
Luxembourg Stock Exchange. The start of trading of Evonik shares in the
regulated market of the Frankfurt and Luxembourg Stock Exchanges is
envisaged for April 25, 2013.

Disclaimer
This disclosure may not be published, distributed or transmitted in the
United States of America, Canada, Australia or Japan. This disclosure does
not constitute an offer of securities for sale or a solicitation of an
offer to purchase securities (the 'Shares') of Evonik Industries AG (the
'Company') in the United States of America, Germany or any other country.
The Shares of the Company may not be offered or sold in the United States
of America absent registration or an exemption from registration under the
U.S. Securities Act of 1933, as amended (the 'Securities Act'). The Shares
of the Company have not been, and will not be, registered under the
Securities Act.

This disclosure constitutes neither an offer to sell nor a solicitation to
buy securities. There will be no public offer of securities of the Company.

In the United Kingdom, this document is only being distributed to and is
only directed at persons who (i) are investment professionals falling
within Article 19(5) of the Financial Services and Markets Act 2000
(Financial Promotion) Order 2005 (as amended) (the 'Order') or (ii) are
persons falling within Article 49(2)(a) to (d) of the Order (high net worth
companies, unincorporated associations, etc.) (all such persons together
being referred to as 'Relevant Persons'). This document is directed only at
Relevant Persons and must not be acted on or relied on by persons who are
not Relevant Persons. Any investment or investment activity to which this
document relates is available only to Relevant Persons and will be engaged
in only with Relevant Persons.

In so far as forecasts or expectations are expressed in this disclosure or
where our statements concern the future, these forecasts, expectations or
statements may involve known or unknown risks and uncertainties. Actual
results or developments may vary, depending on changes in the operating
environment. Neither Evonik Industries AG nor its group companies assume an
obligation to update the forecasts, expectations or statements contained in
this disclosure.

Contact:
Tim Lange
Head of Investor Relations
+49 201 177-3150
tim.lange@evonik.com

24.04.2013 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---

Language: English
Company: Evonik Industries AG
Rellinghauser Straße 1-11
45128 Essen
Germany
Phone: +49 (0) 201 177-01
Fax: +49 (0) 201 177-3475
E-mail: investor-relations@evonik.com
Internet: www.evonik.com
ISIN: DE000EVNK013, XS0911405784, XS0456708212, XS0181557454
WKN: EVNK01, A1TM7T, A1A6MA, 818050
Listed: Regulierter Markt in Frankfurt (Prime Standard); Luxembourg

Notierung vorgesehen / intended to be listed

End of Announcement DGAP News-Service

---